Anti(X)dotes for All? The Role of Replacement and Reversal Strategies in Managing Life-Threatening Bleeding and Emergent Procedures for Patients on Factor Xa Inhibitors

Preview this BCCCP and BCPS recertification offering from the Midyear Clinical Meeting. This session provides a practical approach to managing patients on factor Xa inhibitors with life-threatening bleeding or those needing emergent surgery including guidance on patient selection, indication restrictions and advances in point of care testing. Like what you hear and want to hear the rest and apply what you learn for recertification credit? Visit https://elearning.ashp.org/products/8728/intensive-studies-for-recertification-critical-care-pharmacy-cert-l219022 to purchase the recertification product.    The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.